{"nctId":"NCT00044213","briefTitle":"Trial to Assess Chelation Therapy (TACT)","startDateStruct":{"date":"2003-09"},"conditions":["Coronary Artery Disease"],"count":1708,"armGroups":[{"label":"EDTA + high dose vitamin","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: EDTA","Dietary Supplement: High Dose Vitamin"]},{"label":"EDTA + high dose vitamin placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: EDTA","Dietary Supplement: High Dose Vitamin Placebo"]},{"label":"EDTA placebo + high dose vitamin","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: EDTA Placebo","Dietary Supplement: High Dose Vitamin"]},{"label":"EDTA placebo + high dose vitamin placebo","type":"PLACEBO_COMPARATOR","interventionNames":["Drug: EDTA Placebo","Dietary Supplement: High Dose Vitamin Placebo"]}],"interventions":[{"name":"EDTA","otherNames":[]},{"name":"EDTA Placebo","otherNames":[]},{"name":"High Dose Vitamin","otherNames":[]},{"name":"High Dose Vitamin Placebo","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria for Participants:\n\n* Heart attack at least 6 weeks prior to study start\n\nExclusion Criteria for Participants:\n\n* Serum creatinie level greater than 2.0 mg/dL\n* Platelet count less than 100,000/ÂµL\n* Blood pressure greater than 160/100\n* Chelation therapy within 5 years prior to study start\n* History of allergic reactions to EDTA or any of the therapy's components\n* Coronary or carotid revascularization procedures within 6 months prior to study start or a scheduled revascularization\n* Cigarette smoking within 3 months prior to study start\n* Childbearing potential\n* History of liver disease\n* Active heart failure or heart failure hospitalization within 6 months.\n* Diagnoses of additional medical conditions that could otherwise limit patient survival\n* Inability to tolerate 500-mL infusions weekly.","healthyVolunteers":false,"sex":"ALL","minimumAge":"50 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"A Composite of Total Mortality, Recurrent Myocardial Infarction, Stroke, Coronary Revascularization, and Hospitalization for Angina.","description":"Number of patients with events (composite of death from any cause, MI, stroke, coronary revascularization or hospitalization for angina) Events were centrally adjudicated where available; otherwise site reported events were used.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"108","spread":null},{"groupId":"OG001","value":"114","spread":null},{"groupId":"OG002","value":"122","spread":null},{"groupId":"OG003","value":"139","spread":null}]}]}]},{"type":"SECONDARY","title":"A Composite of Cardiovascular Death, Non-fatal Myocardial Infarction and Non-fatal Stroke.","description":"Number of patients with events (composite of cardiovascular death, non-fatal MI, non-fatal stroke) Events were centrally adjudicated where available; otherwise site reported events were used.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"39","spread":null},{"groupId":"OG001","value":"57","spread":null},{"groupId":"OG002","value":"55","spread":null},{"groupId":"OG003","value":"58","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":421},"commonTop":["Hypocalcaemia","Hypoglycaemia","Proteinuria","Diarrhoea","White Blood Cell Count Decreased"]}}}